Literature DB >> 18811117

Immunofluorescence confocal microscopy of porcine corneas following collagen cross-linking treatment with riboflavin and ultraviolet A.

Kátia M Bottós1, Juliana L Dreyfuss, Caio V S Regatieri, Acácio A S Lima-Filho, Paulo Schor, Helena B Nader, Wallace Chamon.   

Abstract

PURPOSE: To assess ultrastructural stromal modifications in porcine corneas after riboflavin and ultraviolet A (UVA) exposure using immunofluorescence confocal imaging.
METHODS: Twenty-five freshly enucleated porcine eyes were enrolled in the study. Five eyes served as control (group I). Twenty eyes had their epithelium removed (groups I, II, IV, and V) and five eyes had their epithelium intact (group III). Groups II and III were cross-linked with riboflavin 0.1% solution (10 mg riboflavin-5-phosphate in 10 mL 20% dextran-T-500) and exposed to UVA (365 nm, 3 mW/cm2) for 30 minutes. Group IV included five eyes soaked with riboflavin without posterior irradiation, and group V included five eyes irradiated, without previous exposure to riboflavin. Ultra-thin sections (8 microm) of the corneas were stained with anti-collagen I and DAPI and their fluorescence was revealed under confocal microscopy.
RESULTS: Only the cross-linked corneas (group II) showed a pronounced, highly organized anterior fluorescence zone of 182.5 +/- 22.5 microm. Using DAPI staining, an anterior and concentrated displacement of cell nuclei due to collagen compaction was observed after crosslinking (group II). No structural changes were observed in all other groups.
CONCLUSIONS: The cross-linking treatment effect can be directly visualized using confocal fluorescence imaging, allowing for a quantitative analysis. Cross-linked corneas showed a pronounced and limited anterior zone of organized collagen fibers, which was not observed in the other groups. Treatment of the cornea with riboflavin and UVA without previous deepithelialization did not induce any cross-linking effect. Consequently, to facilitate diffusion of riboflavin throughout the corneal stroma, the epithelium should be removed as an important initial step in the treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18811117     DOI: 10.3928/1081597X-20080901-14

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  15 in total

Review 1.  Corneal collagen cross-linking using riboflavin and ultraviolet-A irradiation: a review of clinical and experimental studies.

Authors:  Maria Gkika; Georgios Labiris; Vassilios Kozobolis
Journal:  Int Ophthalmol       Date:  2011-08-17       Impact factor: 2.031

Review 2.  Treatment strategies for corneal ectasia.

Authors:  Jennifer G Bromley; J Bradley Randleman
Journal:  Curr Opin Ophthalmol       Date:  2010-07       Impact factor: 3.761

Review 3.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

4.  Riboflavin concentration in corneal stroma after intracameral injection.

Authors:  Na Li; Xiu-Jun Peng; Zheng-Jun Fan; Xu Pang; Yu Xia; Teng-Fei Wu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  Immunofluorescence of rabbit corneas after collagen cross-linking treatment with riboflavin and ultraviolet A.

Authors:  Salomon Esquenazi; Jiucheng He; Na Li; Haydee E P Bazan
Journal:  Cornea       Date:  2010-04       Impact factor: 2.651

Review 6.  Corneal collagen cross-linking for keratoconus and post-LASIK ectasia.

Authors:  Ronald N Gaster; Ana L Caiado Canedo; Yaron S Rabinowitz
Journal:  Int Ophthalmol Clin       Date:  2013

7.  Collagen cross-linking: current status and future directions.

Authors:  Marine Hovakimyan; Rudolf F Guthoff; Oliver Stachs
Journal:  J Ophthalmol       Date:  2012-01-12       Impact factor: 1.909

8.  Safety and efficacy of epithelium-on corneal collagen cross-linking using a multifactorial approach to achieve proper stromal riboflavin saturation.

Authors:  Aleksandar Stojanovic; Xiangjun Chen; Nan Jin; Ting Zhang; Filip Stojanovic; Sten Raeder; Tor Paaske Utheim
Journal:  J Ophthalmol       Date:  2012-07-30       Impact factor: 1.909

9.  Corneal absorption of a new riboflavin-nanostructured system for transepithelial collagen cross-linking.

Authors:  Katia M Bottos; Anselmo G Oliveira; Patrícia A Bersanetti; Regina F Nogueira; Acácio A S Lima-Filho; José A Cardillo; Paulo Schor; Wallace Chamon
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

Review 10.  Collagen cross linking: current perspectives.

Authors:  Srinivas K Rao
Journal:  Indian J Ophthalmol       Date:  2013-08       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.